CD8A and neoplasm: RT-mediated cell death has been shown to enhance anti-tumor immunity through increasing the levels of proinflammatory cytokines, tumor-associated antigens (TAAs), and damage-associated molecular patterns (DAMPs), which can trigger dendritic cell (DC) maturation and activation of antigen-specific CD8+ T cells [1].